Mediterranean-style diet shown to reduce risk of preeclampsia during pregnancy
Prepare for a healthy pregnancy
Study finds breastfeeding reduces CVD risk in mothers
Guest Commentary | Women and the abortion issue will decide the 2024 election outcome
He is the author of 13 books including Uncommom Sense, the Spiritual Chocolate series, Grandpa's Store, Minister's Guidebook insights from a fellow minister. His column is published weekly in over 600 publications in all 50 states. The views expressed are those of the author and are not necessarily representative of any other group or organization. We welcome comments and views from our readers. Submit your letters to the editor or commentary on a current event 24/7 to editor@oursentinel.com.
The things new moms should know about the 4th trimester
The fourth trimester can have many surprises for first-time mothers. They might experience many physical, mental and emotional changes as their bodies heal and adjust to motherhood. While they may expect certain changes like stretch marks, hair loss and weight fluctuations, many other postpartum adjustments aren't discussed as much.
First Response™ wants to bring awareness to the changes mothers should expect during the fourth trimester. By learning about these changes and how to manage them, women can embrace and accept them with self-compassion and feel empowered to ask for support during their postpartum journey.
1. Postpartum bleeding
If you're a first-time or soon-to-be first-time mom, you may not know you'll experience bleeding after birth. While it may seem scary, this is a very normal part of the postpartum healing process.
According to the Cleveland Clinic, this vaginal discharge is known as lochia and contains a mix of blood, mucus and uterine tissue. It's similar to menstrual blood and can last several weeks, though the heaviness of the discharge should subside over time.
During the first six weeks after giving birth, use sanitary maxi pads (not tampons) to deal with the bleeding. For the first week, expect to go through several pads throughout the day. Most importantly, remember to take it easy and give your body time to heal.
2. Breast engorgement
During the fourth trimester, you may experience breast engorgement until your milk supply regulates. Your breasts may feel swollen, tight and tender, and you may even leak breast milk until symptoms subside, usually within a few days as you begin to regularly breastfeed. Use a cold compress to relieve swelling and pain. If you choose to breastfeed, you can wear a well-fitting bra to provide support and reduce soreness, according to La Leche League International.
If you don't plan to breastfeed, it can take up to several weeks for breast engorgement to subside. During this time, do not pump so your body gets the signal that it doesn't need to produce milk. A cold compress, supportive bra and over-the-counter pain meds can help you manage pain and discomfort until you stop producing milk.
3. Poor sleep
Babies don't have the same sleep schedules as adults. According to the Sleep Foundation, while newborns sleep up to 18 hours a day, they don't sleep in one solid block of time like adults do. Until your baby begins to sleep through the night, you will likely be up several times a night to attend to your baby.
To combat sleep deprivation during the fourth trimester, nap during the day when your baby sleeps. If a partner or family member is helping you, trade off middle-of-the-night feedings. Also, ask friends and family for help with house chores or child care so you can get some well-deserved rest.
4. Postpartum depression
You may have heard of the baby blues when mothers feel overwhelmed, irritable and stressed the first couple of weeks after giving birth. This is your body's natural response to the drop in hormone levels postpartum. However, some women may feel these symptoms more intensely and for long periods, indicating a more serious form of depression.
According to the National Institutes of Health, one in seven women can develop postpartum depression (PPD) within the first six weeks of giving birth. Some symptoms of PPD include:
- Depressed mood
- Loss of interest or pleasure
- Insomnia
- Loss of energy or fatigue
- Feelings of worthlessness or guilt
Because of the societal expectations of motherhood, it can be difficult for women to admit they need help. That's why it's incredibly important for new mothers to have a support system of friends, family and other mothers to help them overcome the stigma of PPD and get the care they need.
If you're experiencing PPD, reach out for help and contact your doctor. While PPD is serious, it is treatable.
Get connected
These are just four ways your life may change after giving birth. While these changes may sound overwhelming, you can manage them with a little help and understanding. That's why First Response has launched the Pregnancy Hub by First Response.
This online community aims to connect, inspire and provide resources to those navigating trying to conceive (TTC), pregnancy and motherhood. By joining, you'll have free access to resources and advice, the opportunity to engage in meaningful conversations with other members, share personal experiences, and more. To learn more and get connected, visit FirstResponsePregnancyHub.SocialMediaLink.com.
**The content provided on this health blog is intended for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.**
Viewpoint |Kamala Harris’ and Donald Trump’s records on abortion policy couldn’t be more different – here’s what actions they both have taken while in office
Rachel Rebouché, Temple University
Abortion is a critical, if not the most important, issue for many voters – especially women, according to polls – ahead of the U.S. presidential election in November.
Since Vice President Kamala Harris became the Democratic presidential nominee in August 2024, she has been vocal about her support for abortion rights. Specifically, she supports Congress passing a federal law that would protect abortion rights in the wake of the Supreme Court in 2022 overturning the landmark Roe v. Wade ruling, which recognized a constitutional right to abortion.
Republican presidential nominee Donald Trump, meanwhile, has boasted about nominating three Supreme Court justices who were among the court majority that voted in 2022 to abandon a constitutional right to abortion. However, in September 2024, Trump said he would not sign a federal abortion ban, reversing course from his previous statements. He also did not answer a question during the September presidential debate about whether he would veto legislation that bans abortion.
Harris and Trump have starkly different track records on abortion. As an academic, my scholarship focuses on reproductive health law, health care law and family law. In this piece, and in anticipation of the election, I briefly consider the broad strokes of each candidate’s past positions on and actions regarding abortion.
As California’s attorney general, Harris co-sponsored the Reproductive FACT Act, which, among other requirements, mandated that crisis pregnancy centers inform patients that they are not licensed medical facilities and that abortion services are available elsewhere. These centers are nonprofit organizations that counsel pregnant people against abortion, sometimes using deceptive tactics.
Anti-abortion groups sued to block the law once it went into effect. And, in 2018, the U.S. Supreme Court struck down the law on First Amendment grounds.
In 2017, Harris investigated the tactics of undercover videographers at Planned Parenthood clinics who, through deception and fraud, sought to entrap clinicians into making controversial, though legal, statements, and who possibly contravened state law on secret recordings.
Conversely, Harris championed various bills that would have protected and advanced reproductive rights. In 2019, for example, Harris was a co-sponsor of the Women’s Health Protection Act, which would have enacted a federal statutory right to abortion. It also did not pass.
Finally, during Harris’ tenure as vice president, the Biden administration has used its executive power to ease barriers to abortion access, primarily through federal agency actions. The Food and Drug Administration, for example, removed a rule in 2021 that prohibited mailing medication abortion.
The Department of Health and Human Services issued guidance affirming that federal law requires emergency rooms to perform an abortion when it is medically necessary to stabilize a patient needing urgent care.
The Biden-Harris administration also supported federal legislation that includes accommodations for abortion. The Pregnant Workers Fairness Act, enacted in 2023, requires employers to provide time off for a worker’s miscarriage, stillbirth or abortion.
Although the Biden-Harris administration’s abortion policy is not necessarily based on just the vice president, Harris, since Roe’s reversal, has been at the helm of the administration’s “Fight for Reproductive Freedoms” tour, speaking nationally in support of a right to abortion. Harris has also stressed the damage done in 14 states, in particular, where abortion is banned throughout pregnancy or after six weeks of gestation.
Trump began his presidency in 2016 by promising to appoint Supreme Court justices who would overturn Roe v. Wade. He nominated three justices – Brett Kavanaugh, Amy Coney Barrett and Neil Gorsuch – who joined the majority opinion in Dobbs v. Jackson Women’s Health Organization, reversing Roe in June 2022.
The Senate confirmed 226 judges whom Trump nominated to the lower levels of federal courts. Trump’s nominations followed a campaign pledge in 2016 that he “would appoint pro-life judges.” Some were on record as being against abortion, and some believed that embryos should be treated like children.
From the start, Trump’s administration prioritized defunding Planned Parenthood clinics, which offer abortion care and receive federal funding under the federal Title X program for other family planning services. Trump signed a bill in 2017 to allow states to strip funding from Planned Parenthood clinics and other organizations that offer abortion, even though abortion care was not supported by the Title X funding.
The Trump administration unsuccessfully tried to replace the Affordable Care Act and undermine its coverage for contraceptives as well as its neutral stance on insurance coverage for abortion. Trump supported bills such as the never-passed American Health Care Act to limit abortion coverage in private health insurance plans.
Trump also appointed several people with anti-abortion positions to his administration, including Charmaine Yoest, the former CEO for the anti-abortion group Americans United for Life, who served as a top communications official at the Department of Health and Human Services.
The Trump administration advanced numerous other anti-abortion policies. For instance, the Department of Human and Health Services’ 2017 strategic plan defined life as beginning at conception – a decision that supported funding for crisis pregnancy centers and abstinence-only education programs.
Finally, the Trump administration adopted an anti-abortion approach when it came to foreign policy. Trump reinstated and expanded the Mexico City Policy, also known as the Global Gag Rule, which prohibits foreign nongovernmental organizations that receive U.S. funding from performing abortions or referring patients for abortion care elsewhere. Under the Mexico City Policy, Trump in 2017 removed US$8.8 billion in U.S. foreign aid for overseas programs that provide or refer for abortions.
In 2017, Trump also suspended U.S. funding to the United Nations Population Fund, an agency focused on family planning for low-income people around the world, among other issues, which does “not promote abortion” but “supports the right of all women to get post-abortion care.” Biden restored funding to the U.N. agency in 2021.
In the coming weeks, both candidates will have a lot to say about abortion, possibly refining or changing their stances on aspects of abortion law. In assessing what both candidates have to say about how their administration will approach abortion, voters might consider what we know about their past actions.Rachel Rebouché is a Professor of Law at Temple University. This article is republished from The Conversation under a Creative Commons license. Read the original article.
Backtracking the Biden-Trump debate, here's what they got wrong, and right
KFF Health News and PolitiFact
President Joe Biden and former President Donald Trump, the presumptive Democratic and Republican presidential nominees, shared a debate stage June 27 for the first time since 2020, in a confrontation that — because of strict debate rules — managed to avoid the near-constant interruptions that marred their previous encounters.
Biden, who spoke in a raspy voice and often struggled to articulate his arguments, said at one point that his administration “finally beat Medicare.” Trump, meanwhile, repeated numerous falsehoods, including that Democrats want doctors to be able to abort babies after birth.
Trump took credit for the Supreme Court’s 2022 decision that upended Roe v. Wade and returned abortion policy to states. “This is what everybody wanted,” he said, adding “it’s been a great thing.” Biden’s response: “It’s been a terrible thing.”
In one notable moment, Trump said he would not repeal FDA approval for medication abortion, used last year in nearly two-thirds of U.S. abortions. Some conservatives have targeted the FDA’s more than 20-year-old approval of the drug mifepristone to further restrict access to abortion nationwide.
“The Supreme Court just approved the abortion pill. And I agree with their decision to have done that, and I will not block it,” Trump said. The Supreme Court ruled this month that an alliance of anti-abortion medical groups and doctors lacked standing to challenge the FDA’s approval of the drug. The court’s ruling, however, did not amount to an approval of the drug.
CNN hosted the debate, which had no audience, at its Atlanta headquarters. CNN anchors Jake Tapper and Dana Bash moderated. The debate format allowed CNN to mute candidates’ microphones when it wasn’t their turn to speak.
Our PolitiFact partners fact-checked the debate in real time as Biden and Trump clashed on the economy, immigration, and abortion, and revisited discussion of their ages. Biden, 81, has become the oldest sitting U.S. president; if Trump defeats him, he would end his second term at age 82. You can read the full coverage here and excerpts detailing specific health-related claims follow:
Biden: “We brought down the price [of] prescription drug[s], which is a major issue for many people, to $15 for an insulin shot, as opposed to $400.”
Half True. Biden touted his efforts to reduce prescription drug costs by referring to the $35 monthly insulin price cap his administration put in place as part of the 2022 Inflation Reduction Act. But he initially flubbed the number during the debate, saying it was lowered to $15. In his closing statement, Biden corrected the amount to $35.
The price of insulin for Medicare enrollees, starting in 2023, dropped to $35 a month, not $15. Drug pricing experts told PolitiFact when it rated a similar claim that most Medicare enrollees were likely not paying a monthly average of $400 before the changes, although because costs vary depending on coverage phases and dosages, some might have paid that much in a given month.
Trump: “I’m the one that got the insulin down for the seniors.”
Mostly False. When he was president, Trump instituted the Part D Senior Savings Model, a program that capped insulin costs at $35 a month for some older Americans in participating drug plans.
But because it was voluntary, only 38% of all Medicare drug plans, including Medicare Advantage plans, participated in 2022, according to KFF. Trump’s plan also covered only one form of each dosage and insulin type.
Biden points to the Inflation Reduction Act’s mandatory $35 monthly insulin cap as a major achievement. This cap applies to all Medicare prescription plans and expanded to all covered insulin types and dosages. Although Trump’s model was a start, it did not have the sweeping reach that Biden’s mandatory cap achieved.
Biden: Trump “wants to get rid of the ACA again.”
Half True. In 2016, Trump campaigned on a promise to repeal and replace the Affordable Care Act, or ACA. In the White House, Trump supported a failed effort to do just that. He repeatedly said he would dismantle the health care law in campaign stops and social media posts throughout 2023. In March, however, Trump walked back this stance, writing on his Truth Social platform that he “isn’t running to terminate” the ACA but to make it “better” and “less expensive.” Trump hasn’t said how he would do this. He has often promised Obamacare replacement plans without ever producing one.
Trump: “The problem [Democrats] have is they’re radical, because they will take the life of a child in the eighth month, the ninth month, and even after birth.”
False. Willfully terminating a newborn’s life is infanticide and illegal in every U.S. state.
Most elected Democrats who have spoken publicly about this have said they support abortion under Roe v. Wade’s standard, which allowed access up to fetal viability — typically around 24 weeks of pregnancy, when the fetus can survive outside the womb. Many Democrats have also said they support abortions past this point if the treating physician deems it necessary.
Medical experts say situations resulting in fetal death in the third trimester are rare — fewer than 1% of abortions in the U.S. occur after 21 weeks — and typically involve fatal fetal anomalies or life-threatening emergencies affecting the pregnant person. For fetuses with very short life expectancies, doctors may induce labor and offer palliative care. Some families choose this option when facing diagnoses that limit their babies’ survival to minutes or days after delivery.
Some Republicans who have made claims similar to Trump’s point to Democratic support of the Women’s Health Protection Act of 2022, which would have prohibited many state government restrictions on access to abortion, citing the bill’s provisions that say providers and patients have the right to perform and receive abortion services without certain limitations or requirements that would impede access. Anti-abortion advocates say the bill, which failed in the Senate by a 49-51 vote, would have created a loophole that eliminated any limits on abortions later in pregnancy.
Alina Salganicoff, director of KFF’s Women’s Health Policy program, said the legislation would have allowed health providers to perform abortions without obstacles such as waiting periods, medically unnecessary tests and in-person visits, or other restrictions. The bill would have allowed an abortion after viability when, according to the bill, “in the good-faith medical judgment of the treating health care provider, continuation of the pregnancy would pose a risk to the pregnant patient’s life or health.”
Trump: “Social Security, he’s destroying it, because millions of people are pouring into our country, and they’re putting them onto Social Security. They’re putting them onto Medicare, Medicaid.”
False. It’s wrong to say that immigration will destroy Social Security. Social Security’s fiscal challenges stem from a shortage of workers compared with beneficiaries.
Immigration is far from a fiscal fix-all for Social Security’s challenges. But having more immigrants in the United States would likely increase the worker-to-beneficiary ratio, potentially for decades, thus extending the program’s solvency.
Most immigrants in the U.S. without legal permission are also ineligible for Social Security. However, people who entered the U.S. without authorization and were granted humanitarian parole — temporary permission to stay in the country — for more than one year are eligible for benefits from the program.
Immigrants lacking legal residency in the U.S. are generally ineligible to enroll in federally funded health care coverage such as Medicare and Medicaid. (Some states provide Medicaid coverage under state-funded programs regardless of immigration status. Immigrants are eligible for emergency Medicaid regardless of their legal status.)
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.
Subscribe to KFF Health News' free Morning Briefing.
April 29 |On this day from the Sentinel
Going into this baseball season, Keegan McCarty had a long list of personal goals he was set on accomplishing this season.
That dream was interrupted by what appeared to be a temporary postponement to the season, and then weeks later the inevitable cancellation of the entire 2020 season, courtesy of the Coronavirus pandemic.
~ Jackson Wooten Do not underestimate yourself.
~ Josh Sexton Get all of your homework finished.
~ Isaac Walden
Backed by plenty of public and private cash, Rapid Covid Tests will be in stores soon
Scientists and lawmakers agree that over-the-counter covid tests could allow desk workers to settle back into their cubicles and make it easier to reopen schools and travel.
But even as entrepreneurs race their products to market, armed with millions of dollars in venture capital and government investment, the demand for covid testing has waned. Manufacturing and bureaucratic delays have also kept rapid tests from hitting store shelves in large numbers, though the industry was energized by the Food and Drug Administration’s greenlighting of two more over-the-counter tests Wednesday.
Corporate giants and startups alike plan to offer a dizzying array of test options, most costing between $10 and $110. Their screening accuracy varies, as does the way consumers get results: collection kits mailed back to a lab, devices synced with artificial intelligence-enabled apps on a smartphone that spit out results within 15 minutes, and credit card-sized tests with strips of paper that must be dipped into a chemical substance.
"At-home tests are one of the key steps to getting back to normal life," said Andy Slavitt, a member of the White House COVID-19 Response Team, during a February briefing.
The Biden administration announced in March it will allocate $10 billion from the recently passed stimulus package for covid testing to expedite school reopenings, and earlier said it would invoke the Defense Production Act to manufacture more at-home tests. Separately, the federal government has already sent millions of Abbott Laboratories’ BinaxNOW rapid tests to states, and California, for instance, is giving 3 million of them to its most disadvantaged school districts for free.
Large employers, like Google, sports leagues and the federal government, have already shelled out millions to regularly test their workers. Amazon just received emergency use authorization from the FDA for its own covid test and home collection kit, which it intends to use for its employee screening program.
Individuals who want to buy over-the-counter tests can bill their health insurance plans, which are required by the federal government in most cases to fully cover covid tests that have been authorized by the FDA.
Everlywell, based in Austin, Texas, is an at-home diagnostic company that already sells its collection kit to consumers through its website and Walgreens, and will soon offer same-day delivery via DoorDash in a dozen cities. Dr. Marisa Cruz, Everlywell’s executive vice president of regulatory and clinical affairs, said buyers can seek reimbursement from their insurance plans for the kit’s $109 cost. The tests are also eligible for purchase with pretax dollars from health savings or flexible spending accounts, she said.
Even with vaccines, epidemiologists say, rapid tests are desperately needed because more testing, along with mask-wearing and physical distancing, will get people back in offices and classrooms and help catch cases that go undetected. A report by the Centers for Disease Control and Prevention found that, of people with active infections, 44% reported no symptoms.
But the market for over-the-counter tests is risky. Demand for testing has plunged dramatically since the height of the winter surge and may not rebound as more people are vaccinated.
'You clearly are at risk of missing the market,' said Michael Greeley, co-founder and general partner at Flare Capital Partners, a venture capital firm focused on health care technology.
But Douglas Bryant, president and CEO of Quidel Corp., remains unfazed, even after the diagnostics manufacturer’s testing demand dropped by about one-third in the past two months.
"The level of testing for people with symptoms and the 'worried well,' who see others getting tested and think they should, too, is subsiding," Bryant said. "But once we start to get more people vaccinated, the government will move from campaigning to get people vaccinated to saying, 'Please test yourself regularly so we can get back to work.'"
Quidel, headquartered in San Diego, recently unveiled its latest test, the QuickVue At-Home COVID-19 Test, which takes 10 minutes to detect the coronavirus by homing in on specific proteins, called antigens. The FDA authorized the test for over-the-counter use Wednesday, and Quidel plans to announce retail partners in the coming weeks.
The FDA said in mid-March it would speed the pipeline for “screening testing,” including at-home covid tests that don’t require consumers to have symptoms or a prescription.
In February, the Biden administration cut a $232 million deal with Ellume, whose rapid antigen test was authorized by the FDA in December. Paired with an app, the test takes 15 minutes to analyze after a nose swab.
The Australian company currently ships hundreds of thousands of test kits a week to the U.S. from its factory in Brisbane to large companies and the Department of Defense. It plans to be on the shelves of multiple pharmacies by the second half of the year and in one major retailer in April, said Dr. Sean Parsons, the company’s founder and CEO.
"We are going as fast as we can possibly go," he said.
The main holdup for Ellume has been getting enough swabs for its production line. The company is building a factory in the U.S. to reduce international shipping costs and increase production.
Abbott, which dominates the rapid-test market, said in January it expects to sell 120 million BinaxNOW antigen tests to consumers in the first half of the year. People who take the test now must do so under observation by telemedicine platform eMed. But Abbott received authorization from the FDA this week for an over-the-counter version that won’t require remote observation or a prescription. The test will be available in U.S. stores in the coming weeks, the company said.
Throughout the pandemic, the government has depended heavily on medical device behemoth Abbott’s testing options. The company’s rapid-diagnostics arm alone has snared $673 million in federal contracts to combat the coronavirus, according to a ProPublica database. This includes bulk purchases made by the Defense Department, the national prison system, Immigration and Customs Enforcement, the State Department and former President Donald Trump's office.
But antigen tests sometimes report false negatives, particularly among people without symptoms, noted Dr. Jac Dinnes, who co-authored a review of 64 covid test studies. By comparison, polymerase chain reaction (PCR) tests — generally employed by commercial labs — are more sensitive. PCR tests search for the virus’s genetic material over multiple testing cycles, which magnifies what’s in the swab sample, requiring a much smaller viral load for detection.
Antigen tests are the basis for most at-home screening, but the FDA has also authorized two at-home options — made by Lucira Health and Cue Health — that use molecular processes similar to a PCR test.
Still, many experts support the widespread distribution of cheap, rapid tests, even if they aren’t as sensitive as lab-run alternatives, and see a demand. In Germany, the supermarket chain Aldi began selling rapid tests in early March, roughly $30 for a five-pack, and sold out within hours. One recent study found that if a pack of tests was mailed to every household in the U.S. — even assuming that up to 75% would go into the garbage — they would save thousands of lives and avert millions of infections.
"Don’t let perfect be the enemy of good," said study co-author and Yale University professor A. David Paltiel. "This doesn’t have to work perfectly to make a huge difference."
Some companies are working on rapid-testing options that more precisely read samples, such as Gauss.
The Menlo Park, California, health tech company, which before the pandemic created an artificial intelligence-based app to measure surgical blood loss in real time, aims to harness its expertise to improve on the basic antigen test. It took about a week for CEO Siddarth Satish to raise $30 million of venture capital last October.
Its covid-testing app uses facial recognition software to confirm that test-takers correctly swab their noses. The app provides step-by-step instructions and timers. After 15 minutes, an algorithm based on thousands of sample tests interprets the result — which displays as a colored line, as with a pregnancy test — using the phone’s camera.
Gauss and Cellex, which manufactures the Gauss tests, await FDA authorization. In the meantime, they have produced more than 1.5 million kits and struck deals with supermarket chain Kroger and e-pharmacy site Truepill to sell them for about $30.
"A huge part of the accuracy issue with rapid tests is that you have to visually interpret them," Satish said. "Sometimes you get really faint lines, just like with a pregnancy strip, and there’s some guesswork."
Lucira Health, based in Emeryville, California, uses something called loop-mediated isothermal amplification technology, which is similar to PCR tests in precision. In February, the company went public, raising $153 million largely to fund the manufacturing of its all-in-one testing kit, currently prescribed by doctors across the country. The kit comes with a nose swab and a vial of chemicals analyzed by a hand-held device — taking up to 30 minutes for results.
Kelly Lewis Brezoczky, Lucira’s executive vice president, envisions the test kit on the shelf in local pharmacies, perched next to the NyQuil. "I always like to tell people that it is as easy to use as toothpaste," she said.
Subscribe to KHN's free Morning Briefing.
OSF Sacred Heart welcomed Ka’Lani Moore, their first baby of 2025
Related articles:
- Latest diet guidelines features new guidance for infants and toddlers
- Prepare for a healthy pregnancy
- Study finds breastfeeding reduces CVD risk in mothers
- Exposing misconceptions about infant nutrition for new moms
The Sentinel On This Day | February 14
Sentinel Article Archive for February 14
Facing inequities in maternal health care, Black mothers are more at risk to receive lower quality care
by Paul ArcoOSF Healthcare
OSF HealthCare Saint Anthony Medical
“I think for black women in the maternal health space, it's being heard and too often, there is a misperception that sometimes is out there regarding their response to pain, their use of drugs and things that are all misconceptions,” she says. “That is a big challenge for us, and that includes me, to overcome. It doesn't matter what level of education or where you live. The research has shown that it is still an issue.” Dr. Davis adds that the medical community can do better when it comes to listening and responding to their patients’ needs. “Every patient is special and different for us to slow down and really look at that person as the person, and understand and listen,” she says. “Sometimes patients, if they're not comfortable, won't disclose what's going on in the first few minutes, but as you get ready to leave, then you might start to get the real back story. And so, it's important for us to slow down and be in the moment.” Another need is for more Black providers, according to Dr. Davis. She says studies have shown that Black patients tend to relate to someone their own color. “It's very important, I think, for that message to be out there and to encourage young people to look at health care as an option, especially young people of color, because in the future, that's what we're going to need.” But there are things patients can do for themselves. Dr. Davis stresses to her patients the importance of making their own health a high priority. That includes maintaining a healthy diet, getting enough rest and exercise and attending prenatal appointments. “If you're not at your best, how can you be good for anyone else?” she asks. “I think what moms suffer from is everyone's important, but sometimes they need to take that step back and focus on themselves, so they can be 100% for their kids, for their spouse, for their parents, for their siblings.”
More articles:
- Ask your healthcare provider if a CT calcium screen is right for you
- Allergy season is just around the corner; some tips that might help you be less miserable
- Supercharge your brain, 20 foods that will boost your brain health
- Lost for Words? Using the wrong words could be an indicator of Alzheimer’s onset
Editor's Choice
Prepared and aware: 4 travel safety tips for your 2026 getaway
If your next trip feels more complicated to plan than you remember, you're not imagining it. Fuel prices, geopolitical tension...




